Probing key coordination interactions: configurationally restricted metal activated CXCR4 antagonists

Area of Science:

• Coordination Chemistry
• Medicinal Chemistry
• Computational Chemistry

Background:

• Development of novel metal complexes for therapeutic applications.
• Investigating structure-activity relationships in antiviral agents.
• Understanding metal-ligand interactions in biological systems.

Purpose of the Study:

• Synthesize and characterize configurationally restricted mono- and bis-macrocyclic copper(II) complexes.
• Determine the solid-state structure of the copper(II) mono-macrocyclic complex.
• Evaluate the in vitro anti-HIV activity of the synthesized complexes.

Main Methods:

• Synthesis of macrocyclic copper(II) perchlorate complexes.
• X-ray crystallography for structural determination.
• Extended X-ray Absorption Fine Structure (EXAFS) studies.
• Density Functional Theory (DFT) calculations.
• In vitro anti-HIV infection assays.

Main Results:

• Successful synthesis and structural characterization of novel copper(II) macrocyclic complexes.
• EXAFS studies confirm copper coordination spheres are consistent in solid state and aqueous solution.
• DFT calculations reveal favorable binding interactions with CXCR4 aspartate residues.
• Configurationally restricted dicopper(II) complex shows enhanced anti-HIV-1 activity (EC(50) = 0.026 microM) compared to non-constrained analog (EC(50) = 0.047 microM).

Conclusions:

• Configurationally restricted macrocyclic copper(II) complexes exhibit potent anti-HIV activity.
• Structural and computational studies provide insights into the mechanism of action.
• These complexes represent promising candidates for further development as antiviral agents.